FAQ: Mileutis Wins 2025 AgTech Breakthrough Award for IMILAC Dairy Solution

What is IMILAC and what does it do?

IMILAC is a milk-derived, residue-free therapy that strengthens cows’ natural immune systems to help prevent and treat mastitis without antibiotics, while also improving milk yield and quality.

Why did Mileutis win the 2025 AgTech Breakthrough Award?

Mileutis won for IMILAC in the Dairy Productivity Solution category, recognized for its innovation in providing a sustainable, antibiotic-free solution that transforms dairy farming practices.

How does IMILAC work to treat mastitis?

IMILAC activates the cow’s immune defenses using naturally occurring milk peptides, replacing antibiotics with a natural, residue-free solution that protects animal health.

What are the main benefits of using IMILAC for dairy farmers?

IMILAC improves milk yield, enhances milk quality, reduces waste from discarded milk, and provides a sustainable path to higher productivity and healthier herds without antibiotics or hormones.

Who are the key people behind Mileutis and this innovation?

David Javier Iscovich is the CEO and Dr. Jose Iscovich is the Chief Scientific Officer, both emphasizing the science-driven innovation and decade of research behind IMILAC.

Why is replacing antibiotics in dairy farming important?

Replacing antibiotics tackles the urgent global challenge of antimicrobial resistance, slows the spread of resistant bacteria, and promotes sustainable farming while maintaining productivity.

What evidence supports IMILAC’s effectiveness?

IMILAC has been proven in large-scale clinical trials and is based on more than a decade of research into milk peptides and their immune-activating capabilities.

Where can I find more information about Mileutis and IMILAC?

For more information, visit www.mileutis.com.